Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.

Harner-Foreman N, Vadakekolathu J, Laversin SA, Mathieu MG, Reeder S, Pockley AG, Rees RC, Boocock DJ.

Sci Rep. 2017 Jan 17;7:40633. doi: 10.1038/srep40633.

2.

The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.

Mathieu MG, Miles AK, Ahmad M, Buczek ME, Pockley AG, Rees RC, Regad T.

Cell Death Dis. 2014 Feb 13;5:e1061. doi: 10.1038/cddis.2014.29.

3.

The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.

Linley AJ, Mathieu MG, Miles AK, Rees RC, McArdle SE, Regad T.

J Biol Chem. 2012 Apr 20;287(17):13633-43. doi: 10.1074/jbc.M111.308973. Epub 2012 Mar 5.

4.

Cancer/testis antigens for therapeutic use.

Mathieu MG, Miles AK, Li G, McArdle SE, Rees RC.

J BUON. 2009 Sep;14 Suppl 1:S97-102. Review.

PMID:
19785076
5.

HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers.

Mathieu MG, Linley AJ, Reeder SP, Badoual C, Tartour E, Rees RC, McArdle SE.

Cancer Immun. 2010 Jan 11;10:2.

6.

Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?

Riley CL, Mathieu MG, Clark RE, McArdle SE, Rees RC.

Cancer Immunol Immunother. 2009 Sep;58(9):1489-99. doi: 10.1007/s00262-009-0675-x. Epub 2009 Mar 4. Review.

PMID:
19259670
7.

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.

Mathieu MG, Knights AJ, Pawelec G, Riley CL, Wernet D, Lemonnier FA, Straten PT, Mueller L, Rees RC, McArdle SE.

Cancer Immunol Immunother. 2007 Dec;56(12):1885-95. Epub 2007 May 9.

PMID:
17487488
8.

The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines.

Assudani DP, Horton RB, Mathieu MG, McArdle SE, Rees RC.

Cancer Immunol Immunother. 2007 Jan;56(1):70-80. Epub 2006 Mar 23. Review.

PMID:
16555057

Supplemental Content

Loading ...
Support Center